PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 17 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OPPENHEIMER ASSET MANAGEMENT INC. | 14 | $13,000 | 15.66% |
| Context Capital Management, LLC | 4,000,000 | $3,802,000 | 6.58% |
| Sage Capital Management, LLC | 2,044,000 | $1,936,000 | 2.51% |
| BASSO CAPITAL MANAGEMENT, L.P. | 14,000,000 | $13,250,000 | 2.03% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,879,000 | $12,219,000 | 1.67% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,960,000 | $8,495,000 | 0.74% |
| WOLVERINE ASSET MANAGEMENT LLC | 21,623,000 | $20,440,000 | 0.46% |
| ZAZOVE ASSOCIATES LLC | 9,870,000 | $9,333,000 | 0.39% |
| IRON Financial LLC | 400,000 | $386,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 21,834,000 | $20,726,000 | 0.30% |